Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Net Income towards Common Stockholders (2020 - 2025)

LifeStance Health (LFST) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with $11.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 264.06% to $11.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.7 million, a 116.82% increase, with the full-year FY2025 number at $9.7 million, up 116.82% from a year prior.
  • Net Income towards Common Stockholders was $11.7 million for Q4 2025 at LifeStance Health, up from $1.1 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $11.7 million in Q4 2025 to a low of -$120.5 million in Q3 2021.
  • A 5-year average of -$39.7 million and a median of -$41.4 million in 2022 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: crashed 3556.71% in 2021, then surged 264.06% in 2025.
  • LifeStance Health's Net Income towards Common Stockholders stood at -$108.0 million in 2021, then soared by 56.81% to -$46.7 million in 2022, then rose by 3.64% to -$45.0 million in 2023, then skyrocketed by 84.18% to -$7.1 million in 2024, then soared by 264.06% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Net Income towards Common Stockholders are $11.7 million (Q4 2025), $1.1 million (Q3 2025), and -$3.8 million (Q2 2025).